Lyra Direct Strep Assay
De Novo DEN140005
Lyra Direct Strep Assay is a medical device (FDA Class II; FDA product code PGX, Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System) made by Quidel Corporation, granted FDA De Novo DEN140005 on 16 Apr 2014, active as of 10 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA De NovoDENG | NumberDEN140005 | Date16 Apr 2014 | StatusActive |
Official records
- FDA De Novo database DEN140005
From the FDA record
- Received by the FDA
- 25 Mar 2014
- FDA decision
- 16 Apr 2014
- FDA review time
- 22 days from receipt to decision
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- De Novo Number
- FDA product code
- PGX
- Device class
- Class II
- Regulation
- 21 CFR Part 866.2680
- Advisory committee
- Microbiology
- FDA decision
- DENG De Novo granted
Similar devices
Other devices filed under FDA product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System).
- GenePOC Strep A by Genepoc, Inc.
- Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab Kit by Alere Scarborough, Inc.
- ALERE I STREP A by Alere Scarborough, Inc.
- LIAISON NES Group A Strep by DiaSorin Molecular LLC
- Xpert Xpress Strep A by CEPHEID
- LIAT STREP A ASSAY by Iquum, Inc.
- ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File Kit by Luminex Corporation
- Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control Pack by Focus Diagnostics, Inc.
- cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190) by Roche Molecular System, Inc.
- Simplexa™ Group A Strep Positive Control Pack MOL2860 by DiaSorin Molecular LLC